查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239491

按類型、移動性、組件、應用劃分的醫療外骨骼（醫療外骨骼）市場：2021-2031 年全球機會分析和行業預測

Medical Exoskeleton Market By Type, By Mobility, By Component, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 264 Pages | 商品交期: 2-3個工作天內

價格

2021年全球醫用外骨骼（medical exoskeletons）市場價值2.325億美元，2022-2031年復合年增長率為29.4%，到2031年增長預計將達到美國2018 年為 30.447 億美元。

醫用外骨骼是一種可穿戴機電設備，開發為外部框架，可穿戴在患者體內以從損傷中恢復並增強生物能力，例如用於步行康復和運動支持的假肢設備。 所以這個框架給你的四肢額外的運動、力量和耐力。 醫用外骨骼用於支持患有各種疾病的殘疾人、殘疾人和弱勢群體，包括脊髓損傷 (SCI)、神經系統疾病、中風和其他創傷以及腦癱。 這些醫用外骨骼通常用於有監督的環境，例如在醫務人員監督下的醫院和康復中心。

醫用外骨骼市場的增長是由各種醫用外骨骼設備的技術進步以及脊髓損傷、多發性硬化症和帕金森病等神經系統疾病患病率上升的驅動力推動的。我來了。 此外，越來越多的殘疾人士預計將推動對醫用外骨骼的需求並促進市場增長。 例如，世界衛生組織 (WHO) 報告稱，到 2022 年 12 月，估計將有 13 億人（佔全球人口的 16%）出現嚴重殘疾。 由於神經系統疾病的流行和人口老齡化，這一數字正在增加。 此外，越來越多的人患有脊髓損傷、多發性硬化症和帕金森病等神經系統疾病，據信這會增加對醫療外骨骼設備的需求並推動市場增長。 例如，根據國家脊髓損傷模型系統數據庫 (NSCMSD)，2022 年 6 月，據報導約有 51,000 人患有脊髓損傷。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅很大
    • 新進入者的威脅很大
    • 競爭激烈
  • 市場動態
    • 司機
      • 神經病患病率增加
      • 脊髓損傷和腦損傷的數量增加
      • 不斷增長的老年人口
    • 約束因素
      • 獲得外骨骼醫療用途批准的監管挑戰
    • 機會
      • 產品批准數量的增加：按市場參與者
      • 關鍵策略採用率的增加：按市場參與者
  • 分析 COVID-19 對市場的影響

第 4 章醫療外骨骼市場：按類型

  • 概覽
    • 市場規模和預測
  • 動力外骨骼
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 被動外骨骼
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章醫療外骨骼市場：按移動性

  • 概覽
    • 市場規模和預測
  • 文具
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 手機
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章醫療外骨骼市場：按組件分類

  • 概覽
    • 市場規模和預測
  • 硬件
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 軟件
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章醫療外骨骼市場：按應用

  • 概覽
    • 市場規模和預測
  • 脊髓損傷
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 中風
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 8 章醫療外骨骼市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和移動性預測
    • 各組成部分的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
  • 歐洲
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和移動性預測
    • 各組成部分的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
  • 亞太地區
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和移動性預測
    • 各組成部分的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 市場規模和按類型預測
    • 市場規模和移動性預測
    • 各組成部分的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測
      • 其他拉丁美洲/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和按類型預測
      • 市場規模和移動性預測
      • 各組成部分的市場規模和預測
      • 市場規模和應用預測

第9章競爭格局

  • 介紹
  • 關鍵成功策略
  • 排名前 10 位的玩家產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 頂級玩家定位，2021

第十章公司簡介

  • CYBERDYNE INC.
  • Ekso Bionics
  • Ergosante
  • B-Temia
  • ExoAtlet
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA（suit X）
  • Human Motion Technologies LLC
  • Wearable Robotics srl
  • DIH Medical
Product Code: A11183

The global medical exoskeleton market was valued at $232.5 million in 2021, and is projected to reach $3,044.7 million by 2031, growing at a CAGR of 29.4% from 2022 to 2031.Medical exoskeleton is a wearable electromechanical device that has been developed as external framework that is worn in the body to help patient recover from an injury and to enhance the biological capabilities such as orthotic devices for gait rehabilitation or locomotion assistance. Therefore, this frame offers limbs extra movement, strength, and endurance. Medical exoskeletons are used to power disabled, injured, or vulnerable people suffering from a variety of medical conditions such as spinal cord injury (SCI), neuropathy, major trauma such as stroke, and cerebral palsy. These medical exoskeletons are typically used in monitored settings such as hospitals and rehab centers under the supervision of medical professionals.

The growth of the medical exoskeleton market is driven by technological advancement for development of different medical exoskeleton devices, and rise in prevalence of spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease, and others. In addition, increase in number of people suffering from disability is anticipated to fuel the demand for medical exoskeleton and is anticipated to drive the growth of the market. For instance, according to World Health Organization (WHO), in December 2022, it was reported that, an estimated 1.3 billion people - or 16% of the global population experience a significant disability. This number is growing because of an increase prevalence of neurological disorders and rise in number of geriatric populations. Moreover, rise in number of people suffering from spinal cord injuries, neurological disorders such as multiple sclerosis, Parkinson's disease and others is attributed to increase the demand for medical exoskeleton devices and boosts the market growth. For instance, according to National Spinal Cord Injury Model Systems Database (NSCMSD), in June 2022, it was reported that, approximately 51000 people are suffering from spinal cord injury.

In addition, rise in prevalence of neurological disorders such as multiple sclerosis, Parkinson's disease and stroke are anticipated to drive the demand for medical exoskeleton devices and fuels the market growth. For instance, according to National Multiple Sclerosis Society, it was reported that, in September 2020, approximately 2.8 million people worldwide are suffering from multiple sclerosis (MS). As per the same source, it was reported that, nearly 1 million of them are living in the U.S. in 2020.

Moreover, rise in healthcare expenditure, increase in disposable income, and expansion of middle-class population in developing countries are expected to create lucrative growth opportunities to drive the growth of the medical exoskeleton market. In addition, geriatric population is susceptible to neurological disorders and orthopedic diseases. Thus, rise in number of geriatric population is anticipated to fuel the demand for medical exoskeleton devices and drive the market growth. For instance, according to Population Reference Bureau, in 2019, regions such as Asia and Europe are home to some of the world's oldest populations, those ages 65 and above. Top countries include Japan at 28%, followed by Italy at 23%. Finland, Portugal, and Greece round out the top five at just under 22%.

Moreover, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and application used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for medical exoskeleton application in disabled population, thereby boosting the market growth.

On the other hand, high cost of medical exoskeleton devices and safety concern for devices are some factors that are anticipated to restrain the growth of the medical exoskeleton market.

The medical exoskeleton market is segmented into type, component, mobility, and application. Based on type, the market is divided into powered exoskeleton and passive exoskeleton. Based on component, the market is divided into hardware and software. Based on mobility, the market is bifurcated into stationary and mobile. Based on application, the market is divided into spinal cord injury, stroke, and others. The others segment includes multiple sclerosis, osteoarthritis, Parkinson's disease and acquired brain injuries. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global medical exoskeleton market include: CYBERDYNE INC., Ekso Bionics, Ergosante, B-Temia, ExoAtlet, ReWalk Robotics., Ottobock SE & Co. KGaA (suit X), DIH medical Hocoma., Human Motion Technologies LLC., and Wearable Robotics srl.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical exoskeleton market analysis from 2021 to 2031 to identify the prevailing medical exoskeleton market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical exoskeleton market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical exoskeleton market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Powered exoskeleton
  • Passive exoskeleton

By Mobility

  • Stationary
  • Mobile

By Component

  • Hardware
  • Software

By Application

  • Spinal Cord Injury
  • Stroke
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • CYBERDYNE INC.
  • Ekso Bionics
  • B-Temia
  • Rewalk Robotics
  • Ottobock SE & Co. KGaA (suit X)
  • DIH Medical
  • Ergosante
  • ExoAtlet
  • Human Motion Technologies LLC
  • Wearable Robotics srl

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of neurological disorders.
      • 3.4.1.2. Increase in the number of spinal cord injuries and brain injuries.
      • 3.4.1.3. Rise in the number of geriatric populations.
    • 3.4.2. Restraints
      • 3.4.2.1. Regulatory challenges for securing approvals for medical applications of exoskeletons.
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of product approvals by market players.
      • 3.4.3.2. Rise in the number of adoptions of key strategies by market players
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL EXOSKELETON MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Powered exoskeleton
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Passive exoskeleton
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL EXOSKELETON MARKET, BY MOBILITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Stationary
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Mobile
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: MEDICAL EXOSKELETON MARKET, BY COMPONENT

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hardware
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Software
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: MEDICAL EXOSKELETON MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Spinal Cord Injury
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Stroke
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL EXOSKELETON MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Mobility
    • 8.2.4. Market size and forecast, by Component
    • 8.2.5. Market size and forecast, by Application
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Mobility
      • 8.2.6.1.4. Market size and forecast, by Component
      • 8.2.6.1.5. Market size and forecast, by Application
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Mobility
      • 8.2.6.2.4. Market size and forecast, by Component
      • 8.2.6.2.5. Market size and forecast, by Application
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Mobility
      • 8.2.6.3.4. Market size and forecast, by Component
      • 8.2.6.3.5. Market size and forecast, by Application
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Mobility
    • 8.3.4. Market size and forecast, by Component
    • 8.3.5. Market size and forecast, by Application
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Mobility
      • 8.3.6.1.4. Market size and forecast, by Component
      • 8.3.6.1.5. Market size and forecast, by Application
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Mobility
      • 8.3.6.2.4. Market size and forecast, by Component
      • 8.3.6.2.5. Market size and forecast, by Application
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Mobility
      • 8.3.6.3.4. Market size and forecast, by Component
      • 8.3.6.3.5. Market size and forecast, by Application
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Mobility
      • 8.3.6.4.4. Market size and forecast, by Component
      • 8.3.6.4.5. Market size and forecast, by Application
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Mobility
      • 8.3.6.5.4. Market size and forecast, by Component
      • 8.3.6.5.5. Market size and forecast, by Application
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Mobility
      • 8.3.6.6.4. Market size and forecast, by Component
      • 8.3.6.6.5. Market size and forecast, by Application
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Mobility
    • 8.4.4. Market size and forecast, by Component
    • 8.4.5. Market size and forecast, by Application
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Mobility
      • 8.4.6.1.4. Market size and forecast, by Component
      • 8.4.6.1.5. Market size and forecast, by Application
      • 8.4.6.2. China
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Mobility
      • 8.4.6.2.4. Market size and forecast, by Component
      • 8.4.6.2.5. Market size and forecast, by Application
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Mobility
      • 8.4.6.3.4. Market size and forecast, by Component
      • 8.4.6.3.5. Market size and forecast, by Application
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Mobility
      • 8.4.6.4.4. Market size and forecast, by Component
      • 8.4.6.4.5. Market size and forecast, by Application
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Mobility
      • 8.4.6.5.4. Market size and forecast, by Component
      • 8.4.6.5.5. Market size and forecast, by Application
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Mobility
      • 8.4.6.6.4. Market size and forecast, by Component
      • 8.4.6.6.5. Market size and forecast, by Application
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Mobility
    • 8.5.4. Market size and forecast, by Component
    • 8.5.5. Market size and forecast, by Application
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Mobility
      • 8.5.6.1.4. Market size and forecast, by Component
      • 8.5.6.1.5. Market size and forecast, by Application
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Mobility
      • 8.5.6.2.4. Market size and forecast, by Component
      • 8.5.6.2.5. Market size and forecast, by Application
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Mobility
      • 8.5.6.3.4. Market size and forecast, by Component
      • 8.5.6.3.5. Market size and forecast, by Application
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Mobility
      • 8.5.6.4.4. Market size and forecast, by Component
      • 8.5.6.4.5. Market size and forecast, by Application

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. CYBERDYNE INC.
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. Ekso Bionics
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Ergosante
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
  • 10.4. B-Temia
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. ExoAtlet
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. Rewalk Robotics
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Ottobock SE & Co. KGaA (suit X)
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
  • 10.8. Human Motion Technologies LLC
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Wearable Robotics srl
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. DIH Medical
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. MEDICAL EXOSKELETON MARKET FOR MOBILE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. GLOBAL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. MEDICAL EXOSKELETON MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. MEDICAL EXOSKELETON MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. MEDICAL EXOSKELETON MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. U.S. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. U.S. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. CANADA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. CANADA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. MEXICO MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. FRANCE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. UK MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. UK MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ITALY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ITALY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ITALY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. SPAIN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. SPAIN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. SPAIN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. SPAIN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. JAPAN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. JAPAN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. JAPAN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. JAPAN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. CHINA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. CHINA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. CHINA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. CHINA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. INDIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. INDIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. INDIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. INDIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. LAMEA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. BRAZIL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. BRAZIL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 106. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 107. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 108. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 109. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 110. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 111. CYBERDYNE INC.: KEY EXECUTIVES
  • TABLE 112. CYBERDYNE INC.: COMPANY SNAPSHOT
  • TABLE 113. CYBERDYNE INC.: PRODUCT SEGMENTS
  • TABLE 114. CYBERDYNE INC.: PRODUCT PORTFOLIO
  • TABLE 115. CYBERDYNE INC.: KEY STRATERGIES
  • TABLE 116. EKSO BIONICS: KEY EXECUTIVES
  • TABLE 117. EKSO BIONICS: COMPANY SNAPSHOT
  • TABLE 118. EKSO BIONICS: PRODUCT SEGMENTS
  • TABLE 119. EKSO BIONICS: PRODUCT PORTFOLIO
  • TABLE 120. EKSO BIONICS: KEY STRATERGIES
  • TABLE 121. ERGOSANTE: KEY EXECUTIVES
  • TABLE 122. ERGOSANTE: COMPANY SNAPSHOT
  • TABLE 123. ERGOSANTE: PRODUCT SEGMENTS
  • TABLE 124. ERGOSANTE: PRODUCT PORTFOLIO
  • TABLE 125. B-TEMIA: KEY EXECUTIVES
  • TABLE 126. B-TEMIA: COMPANY SNAPSHOT
  • TABLE 127. B-TEMIA: PRODUCT SEGMENTS
  • TABLE 128. B-TEMIA: PRODUCT PORTFOLIO
  • TABLE 129. B-TEMIA: KEY STRATERGIES
  • TABLE 130. EXOATLET: KEY EXECUTIVES
  • TABLE 131. EXOATLET: COMPANY SNAPSHOT
  • TABLE 132. EXOATLET: PRODUCT SEGMENTS
  • TABLE 133. EXOATLET: PRODUCT PORTFOLIO
  • TABLE 134. REWALK ROBOTICS: KEY EXECUTIVES
  • TABLE 135. REWALK ROBOTICS: COMPANY SNAPSHOT
  • TABLE 136. REWALK ROBOTICS: PRODUCT SEGMENTS
  • TABLE 137. REWALK ROBOTICS: PRODUCT PORTFOLIO
  • TABLE 138. REWALK ROBOTICS: KEY STRATERGIES
  • TABLE 139. OTTOBOCK SE & CO. KGAA (SUIT X): KEY EXECUTIVES
  • TABLE 140. OTTOBOCK SE & CO. KGAA (SUIT X): COMPANY SNAPSHOT
  • TABLE 141. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT SEGMENTS
  • TABLE 142. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT PORTFOLIO
  • TABLE 143. HUMAN MOTION TECHNOLOGIES LLC: KEY EXECUTIVES
  • TABLE 144. HUMAN MOTION TECHNOLOGIES LLC: COMPANY SNAPSHOT
  • TABLE 145. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT SEGMENTS
  • TABLE 146. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT PORTFOLIO
  • TABLE 147. WEARABLE ROBOTICS SRL: KEY EXECUTIVES
  • TABLE 148. WEARABLE ROBOTICS SRL: COMPANY SNAPSHOT
  • TABLE 149. WEARABLE ROBOTICS SRL: PRODUCT SEGMENTS
  • TABLE 150. WEARABLE ROBOTICS SRL: PRODUCT PORTFOLIO
  • TABLE 151. DIH MEDICAL: KEY EXECUTIVES
  • TABLE 152. DIH MEDICAL: COMPANY SNAPSHOT
  • TABLE 153. DIH MEDICAL: PRODUCT SEGMENTS
  • TABLE 154. DIH MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL EXOSKELETON MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL EXOSKELETON MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL EXOSKELETON MARKET
  • FIGURE 10. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR MOBILE, BY COUNTRY 2021-2031(%)
  • FIGURE 16. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR STROKE, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL EXOSKELETON MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 23. MEDICAL EXOSKELETON MARKET BY REGION, 2021
  • FIGURE 24. U.S. MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. CANADA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. MEXICO MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. GERMANY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. FRANCE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. UK MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. ITALY MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. SPAIN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. REST OF EUROPE MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. JAPAN MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. CHINA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. AUSTRALIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH KOREA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. BRAZIL MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. REST OF LAMEA MEDICAL EXOSKELETON MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: MEDICAL EXOSKELETON MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2021
  • FIGURE 50. CYBERDYNE INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. CYBERDYNE INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 52. EKSO BIONICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. EKSO BIONICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 54. EKSO BIONICS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. EKSO BIONICS: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 56. REWALK ROBOTICS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 57. REWALK ROBOTICS: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 58. REWALK ROBOTICS: REVENUE SHARE BY REGION, 2021 (%)